Literature DB >> 18270373

Adiposity, physical activity, and pancreatic cancer in the National Institutes of Health-AARP Diet and Health Cohort.

Rachael Z Stolzenberg-Solomon1, Kenneth Adams, Michael Leitzmann, Catherine Schairer, Dominique S Michaud, Albert Hollenbeck, Arthur Schatzkin, Debra T Silverman.   

Abstract

Obesity and lack of physical activity have been inconsistently associated with pancreatic cancer. Using data from a self-administered baseline questionnaire (1995-1996), the authors investigated the association between adiposity and physical activity and pancreatic cancer in 495,035 participants of the National Institutes of Health-AARP Diet and Health Study who were aged 50-71 years. To avoid the influence of subclinical disease, follow-up time started 1 year after baseline, and subjects with a body mass index (BMI) of <18.5 kg/m(2) were excluded. A subcohort (n = 302,060) completed a second questionnaire with information about physical activity and waist and hip circumference. During follow-up though 2000, 654 pancreatic cancer cases were identified. The authors used Cox proportional hazard models to generate adjusted hazard ratios and 95% confidence intervals. Compared with those with a BMI of 18.5-<25, those with a BMI of >/=35 had a 45% greater pancreatic cancer risk (95% confidence interval (CI): 1.04, 2.02; p(trend) = 0.02). Significant positive associations for BMI were observed among nonsmokers (for BMI > or =35: hazard ratio = 1.70, 95% CI: 1.14, 2.53; p(trend) = 0.004) but not recent smokers (p(interaction) = 0.08). Waist circumference was positively associated with pancreatic cancer (fourth vs. first quartile: hazard ratio = 2.53, 95% CI: 1.13, 5.65; p(trend) = 0.04) in women but not men. The authors observed no association with physical activity. Their results suggest a positive association between adiposity and pancreatic cancer.

Entities:  

Mesh:

Year:  2008        PMID: 18270373     DOI: 10.1093/aje/kwm361

Source DB:  PubMed          Journal:  Am J Epidemiol        ISSN: 0002-9262            Impact factor:   4.897


  41 in total

1.  Prediagnostic adiponectin concentrations and pancreatic cancer risk in male smokers.

Authors:  Rachael Z Stolzenberg-Solomon; Stephanie Weinstein; Michael Pollak; Yuzhen Tao; Philip R Taylor; Jarmo Virtamo; Demetrius Albanes
Journal:  Am J Epidemiol       Date:  2008-09-18       Impact factor: 4.897

2.  Dietary food groups intake and cooking methods associations with pancreatic cancer: a case-control study.

Authors:  Zeinab Ghorbani; Azita Hekmatdoost; Hassan Eini Zinab; Solmaz Farrokhzad; Roya Rahimi; Reza Malekzadeh; Akram Pourshams
Journal:  Indian J Gastroenterol       Date:  2015-06-12

Review 3.  Physical activity and risk of pancreatic cancer: a systematic review and meta-analysis.

Authors:  Gundula Behrens; Carmen Jochem; Daniela Schmid; Marlen Keimling; Cristian Ricci; Michael F Leitzmann
Journal:  Eur J Epidemiol       Date:  2015-03-15       Impact factor: 8.082

4.  Does body mass index/morbid obesity influence outcome in patients who undergo pancreatoduodenectomy for pancreatic adenocarcinoma?

Authors:  Saboor Khan; Guido Sclabas; Kaye Reid-Lombardo; Michael G Sarr; David Nagorney; Michael L Kendrick; Florencia G Que; John H Donohue; Marianne Huebner; Christine Lohse; Michael B Farnell
Journal:  J Gastrointest Surg       Date:  2010-07-30       Impact factor: 3.452

5.  Body mass index, effect modifiers, and risk of pancreatic cancer: a pooled study of seven prospective cohorts.

Authors:  Li Jiao; Amy Berrington de Gonzalez; Patricia Hartge; Ruth M Pfeiffer; Yikyung Park; D Michal Freedman; Mitchell H Gail; Michael C R Alavanja; Demetrius Albanes; Laura E Beane Freeman; Wong-Ho Chow; Wen-Yi Huang; Richard B Hayes; Jane A Hoppin; Bu-Tian Ji; Michael F Leitzmann; Martha S Linet; Cari L Meinhold; Catherine Schairer; Arthur Schatzkin; Jarmo Virtamo; Stephanie J Weinstein; Wei Zheng; Rachael Z Stolzenberg-Solomon
Journal:  Cancer Causes Control       Date:  2010-04-10       Impact factor: 2.506

6.  Adipocytes enhance murine pancreatic cancer growth via a hepatocyte growth factor (HGF)-mediated mechanism.

Authors:  Kathryn M Ziegler; Robert V Considine; Eben True; Deborah A Swartz-Basile; Henry A Pitt; Nicholas J Zyromski
Journal:  Int J Surg       Date:  2016-03-05       Impact factor: 6.071

7.  Cardiorespiratory fitness and digestive cancer mortality: findings from the aerobics center longitudinal study.

Authors:  J Brent Peel; Xuemei Sui; Charles E Matthews; Swann A Adams; James R Hébert; James W Hardin; Timothy S Church; Steven N Blair
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2009-03-17       Impact factor: 4.254

8.  Physical activity, diet, and pancreatic cancer: a population-based, case-control study in Minnesota.

Authors:  Jianjun Zhang; Ishwori B Dhakal; Myron D Gross; Nicholas P Lang; Fred F Kadlubar; Lisa J Harnack; Kristin E Anderson
Journal:  Nutr Cancer       Date:  2009       Impact factor: 2.900

9.  Association of body mass index and risk of death from pancreas cancer in Asians: findings from the Asia Cohort Consortium.

Authors:  Yingsong Lin; Rong Fu; Eric Grant; Yu Chen; Jung Eun Lee; Prakash C Gupta; Kunnambath Ramadas; Manami Inoue; Shoichiro Tsugane; Yu-Tang Gao; Akiko Tamakoshi; Xiao-Ou Shu; Kotaro Ozasa; Ichiro Tsuji; Masako Kakizaki; Hideo Tanaka; Chien-Jen Chen; Keun-Young Yoo; Yoon-Ok Ahn; Habibul Ahsan; Mangesh S Pednekar; Catherine Sauvaget; Shizuka Sasazuki; Gong Yang; Yong-Bing Xiang; Waka Ohishi; Takashi Watanabe; Yoshikazu Nishino; Keitaro Matsuo; San-Lin You; Sue K Park; Dong-Hyun Kim; Faruque Parvez; Betsy Rolland; Dale McLerran; Rashmi Sinha; Paolo Boffetta; Wei Zheng; Mark Thornquist; Ziding Feng; Daehee Kang; John D Potter
Journal:  Eur J Cancer Prev       Date:  2013-05       Impact factor: 2.497

10.  Predictors of fasting serum insulin and glucose and the risk of pancreatic cancer in smokers.

Authors:  Cari L Meinhold; Amy Berrington de Gonzalez; Demetrius Albanes; Stephanie J Weinstein; Philip R Taylor; Jarmo Virtamo; Rachael Z Stolzenberg-Solomon
Journal:  Cancer Causes Control       Date:  2008-12-13       Impact factor: 2.506

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.